According to a survey by Sina Publisher, China at present has over 100 different stem cell industry-related enterprises. Since 2011, when the State Health Commission and the Food and Drug Administration jointly stopped stem cell clinical research and application projects, many non-qualified medical institutions and companies went out of business, a new industrial chain of competent companies has developed, with a growth rate of 50 % per year. At present 143 domestic stem cell related enterprises are located mainly in Beijing, Shanghai, Jiangsu, Guangdong and Shandong. In Jiangsu Province, Taizhou’s China Medical City hosts the national stem cell industrialization project. In addition, Wuxi has an International Stem Cell Joint Research Center with the UK, and Shandong offers the Qingdao stem cell industrialization base. Beijing, Tianjin, Shandong, Shanghai, Zhejiang, Guangdong, Sichuan and seven other provinces (municipalities) hold a national license of umbilical cord blood stem cell banks. By 2020, China’s stem cell industry market is expected to reach nearly 150 billion yuan.
China Bio news release, October 9, 2017